Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine

MHRA safety review of medicines containing pseudoephedrine

Adverse Drug Effects: A Nursing Concern

Clinical relevance of reversible cerebral vasoconstriction syndrome in pregnant women with posterior reversible encephalopathy syndrome: review of case reports in Japan

Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition - ScienceDirect

Neuroimaging findings of posterior reversible encephalopathy syndrome (PRES) following haematopoietic stem cell transplantation in paediatric recipients, BMC Pediatrics

药物办公室– 药剂业界主页

藥物辦公室– 藥劑業界主頁

PDF) Decongestant use and the risk of myocardial infarction and stroke: a case-crossover study

药物办公室- 消费者主页

Cerebrovascular Dysregulation: Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.

Clinical Drug Base, PDF, Migraine

藥物辦公室– 藥劑業界主頁

藥物辦公室- 消費者主頁